Exercise Therapy in Patients With Knee Osteoarthritis
2 other identifiers
interventional
189
1 country
1
Brief Summary
Osteoarthritis (OA) is one of the most common form of chronic diseases in the adult population, and approximately 800 000 people in Sweden (population of 9 million people) suffer from this disease, which causes joint pain, stiffness, swelling, loss of function and sick leave. There is increasing evidence that exercise therapy is effective for patients with knee OA. However, there is little knowledge on long-term effects and what type of exercises dosage is most effective. In this present clinical trial, which is a Nordic collaborative project with researchers from different research groups in Sweden and Norway, we intend to investigate short and long-term effects comparing high dosage exercise therapy (each treatment lasting 80 to 90 min) vs. a relatively low dosage exercise program (25 to 30 min) in patients diagnosed with knee OA. Patients in both intervention groups receive three treatments a week for 12 weeks making a total of 36 treatments. Primary outcome is pain-ratings and function (The Knee Injury and Osteoarthritis Outcome Score (KOOS)). Secondary outcome concerns various health-ratings and objective functional tests. Regarding predictors for outcome, we plan also to investigate different psychosocial variables as well as patient's beliefs regarding exercise. Feasibility of how high-dose exercise therapy actually works in primary care health care settings is also planned to be reported. Patients are being assessed by blinded assessor at inclusion, at end of intervention (3 mo), and at six and 12 mo after end of treatment. We plan to include a total of 200 subjects from primary health care settings, two in Norway and two in Sweden, with radiographic-verified knee OA with knee pain and decreased function. The patients have to be within the 45 to 85 age group. Patients are excluded if they have been scheduled for knee surgery or have some other form of illness/disease that limits the exercise tolerance (e.g. heart disease or systemic/metabolic diseases or chronic obstructive airways disease). A major goal is to grade exercises so that they are performed pain-free or close to pain-free in both intervention groups. The principle of deloading is used to meet this goal using a high number of repetitions in sets as pain modulation. The results from this study will give new information about the effectiveness of graded exercise therapy in patients with knee OA, and new knowledge if outcome can be related to the exercise dosage performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Dec 2013
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 17, 2013
CompletedFirst Posted
Study publicly available on registry
December 31, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedJanuary 3, 2020
January 1, 2020
3.8 years
December 17, 2013
January 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Self-assessed function (KOOS) at three months follow-up (other follow-ups with this measure includes six and 12 months follow-up).
The primary outcome measure is the disease specific Knee injury and Osteoarthritis Outcome Score (KOOS). The KOOS assesses the patients' self-report of pain, other symptoms, activities of daily living, sport and recreation function, and knee-related quality of life, answering 42 questions which take about 10 minutes to complete. The KOOS is scored from 0 to 100, separately for each subscale, 0 indicating extreme problems and 100 indicating no problems.
At three months follow-up, i.e. after end of treatment (primary end point). In addition, during the intervention period, the KOOS are assessed after every sixth treatment meaning after 2, 4, 6, 8, 10 weeks, as well as at 6 and 12 months follow-up.
Secondary Outcomes (5)
Patient Satisfaction
After treatment at three months follow-up
Anxiety and depression
At baseline, at three months, at six months and at one year follow-up
Catastrophizing
At baseline, at three months, at six months and at one year follow-up
Tama Scale of Kinesiophobia (TSK)
At baseline, at three months, at six months and at one year follow-up
Change from baseline in self assessed pain using a visal analogue scale (VAS) at three months follow-up (other follow-ups with this measure includes six and 12 months follow-up)
At three months follow-up, i.e. after end of treatment. In addition, during the intervention period, the VAS are assessed after every sixth treatment meaning after 2, 4, 6, 8, 10 weeks, as well as at 6 and 12 months follow-up.
Other Outcomes (4)
20 min walk test.
At inclusion and at three months follow-up, i.e. after end of treatment
30s Maximal Repeated Unilateral Knee Bending test
At inclusion and at three months follow-up, i.e. after end of treatment
the Five Time Repeated Chair Stands.
At inclusion and at three months follow-up, i.e. after end of treatment
- +1 more other outcomes
Study Arms (2)
High dosage exercise therapy
EXPERIMENTALThe high-dosage exercise treatment will be conducted under supervision of experienced physiotherapists, and it follows an exercise protocol previously described as Medical Exercise Therapy, MET. The regimen contains different semi-global and local exercises for the knee. To be able to reach a high number of repetitions despite ongoing pain, the principle of de-loading (reducing weight) will be applied. The use of de-loading allows high number of repetitions nearly or entirely pain free. Later, as the patient improves and tolerates increased loading, the exercises are adapted to be more functional, using closed chain exercises without de-loading the body. Each of the exercises will be performed in 3 sets of 30 repetitions with 30-60s rest in between. Global exercises using a stationary bike will be performed three times during one treatment-session; first 20 minutes as global pain modulation, ten minutes in the middle of the treatment, and then ten minutes at the end of the treatment.
Lower dosage exercise therapy
ACTIVE COMPARATORPatients in the comparison-/control group will perform six exercises, of which, five will be in 2 sets of 10 repetitions combining local and semi-global exercises, again using the principle of de-loading. The five semi-global and local exercises are the same as performed in the MET-group, and the regimen will be supervised in the same manner as for the MET-group. The therapy starts with 10 minutes using a stationary bike, and the same principles will be applied as for the MET-group regarding grading and follow-up with exercises and adjusting the exercises so that they are performed close to pain-free.
Interventions
Eligibility Criteria
You may qualify if:
- age 45-85 yrs with an x-ray verified knee osteoarthritis with pain and decreased function.
You may not qualify if:
- Inflammatory joint disease, current anterior cruciate ligament injury, hip symptoms more aggravating than the knee symptoms, scheduled to have knee replacement surgery within 12 months, and co-morbidities not allowing exercise like cardiovascular, respiratory, systemic, or metabolic conditions limiting exercise tolerance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Västervik hospital (Västervik, Sweden; recruiting clinical unit)collaborator
- City Rehab (Luleå, Sweden; recruiting clinical unit)collaborator
- Moholt Fysioterapi (Trondheim, Norway; recruiting clinical unit)collaborator
- Rosenborg klinikken (Trondheim, Norway; recruiting clinical unit)collaborator
- Frisk 3 (Mosjöen, Norway; recruiting clinical unit)collaborator
- NTNU (Norwegian Univ Science and Tech), Faculty of Health and Social Sciencescollaborator
Study Sites (1)
Karolinska Institutet
Huddinge, Stockholm County, SE-14183, Sweden
Related Publications (3)
Rugelbak GM, Torstensen TA, Paulsberg F, Grooten WJA, Osteras H. Does exercise adherence influence outcome in knee osteoarthritis? - a secondary analysis of a superiority randomized controlled trial. Physiother Theory Pract. 2025 Oct 31:1-15. doi: 10.1080/09593985.2025.2579576. Online ahead of print.
PMID: 41170926DERIVEDTorstensen TA, Osteras H, LoMartire R, Rugelbak GM, Grooten WJA, Ang BO. High- Versus Low-Dose Exercise Therapy for Knee Osteoarthritis : A Randomized Controlled Multicenter Trial. Ann Intern Med. 2023 Feb;176(2):154-165. doi: 10.7326/M22-2348. Epub 2023 Jan 24.
PMID: 36689746DERIVEDTorstensen TA, Grooten WJA, Osteras H, Heijne A, Harms-Ringdahl K, Ang BO. How does exercise dose affect patients with long-term osteoarthritis of the knee? A study protocol of a randomised controlled trial in Sweden and Norway: the SWENOR Study. BMJ Open. 2018 May 5;8(5):e018471. doi: 10.1136/bmjopen-2017-018471.
PMID: 29730615DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Björn O Äng, Assoc.prof
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 17, 2013
First Posted
December 31, 2013
Study Start
December 1, 2013
Primary Completion
August 31, 2017
Study Completion
September 30, 2021
Last Updated
January 3, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
This is currently not planned, but may be necessary depending on the requirements of future financiers (it will then be necessary to compliment our ethical application). Data monitoring ("yes", as indicated above) concerns an external person that will monitor our data, and log results in a notebook